{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:35:49Z","timestamp":1787319349084,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00417-024-06710-8","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T01:21:28Z","timestamp":1733966488000},"page":"925-934","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Topical losartan ophthalmic drops \u2013 a review of corneal wound healing and topical losartan for managing corneal haze and potential future indications"],"prefix":"10.1007","volume":"263","author":[{"given":"Mariam","family":"Abdelghaffar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-3691","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"G\u00fcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5176-1411","authenticated-orcid":false,"given":"Nuno","family":"Moura-Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"3","key":"6710_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/jovr.jovr_114_17","volume":"12","author":"H Bashir","year":"2017","unstructured":"Bashir H, Seykora JT, Lee V (2017) Invisible Shield: Review of the Corneal Epithelium as a Barrier to UV Radiation, Pathogens, and Other Environmental Stimuli. J Ophthalmic Vis Res 12(3):305\u2013311. https:\/\/doi.org\/10.4103\/jovr.jovr_114_17","journal-title":"J Ophthalmic Vis Res"},{"issue":"9","key":"6710_CR2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jfo.2021.05.006","volume":"44","author":"S Charpentier","year":"2021","unstructured":"Charpentier S, Keilani C, Mar\u00e9chal M, Friang C, De Faria A, Froussart-Maille F, Delbarre M (2021) Corneal haze post photorefractive keratectomy. J Fr Ophtalmol 44(9):1425\u20131438. https:\/\/doi.org\/10.1016\/j.jfo.2021.05.006","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"6710_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/IIO.0000000000000112","volume":"56","author":"JA Margo","year":"2016","unstructured":"Margo JA, Munir WM (2016) Corneal Haze Following Refractive Surgery: A Review of Pathophysiology, Incidence, Prevention, and Treatment. Int Ophthalmol Clin 56(2):111\u2013125. https:\/\/doi.org\/10.1097\/IIO.0000000000000112","journal-title":"Int Ophthalmol Clin"},{"issue":"9","key":"6710_CR4","doi-asserted-by":"publisher","first-page":"S824","DOI":"10.3928\/1081597X-20090813-12","volume":"25","author":"F Raiskup","year":"2009","unstructured":"Raiskup F, Hoyer A, Spoerl E (2009) Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 25(9):S824\u2013S828. https:\/\/doi.org\/10.3928\/1081597X-20090813-12","journal-title":"J Refract Surg"},{"issue":"12","key":"6710_CR5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.4103\/ijo.IJO_871_17","volume":"65","author":"N Sharma","year":"2017","unstructured":"Sharma N, Singhal D, Nair SP, Sahay P, Sreeshankar SS, Maharana PK (2017) Corneal edema after phacoemulsification. Indian J Ophthalmol 65(12):1381\u20131389. https:\/\/doi.org\/10.4103\/ijo.IJO_871_17","journal-title":"Indian J Ophthalmol"},{"key":"6710_CR6","volume-title":"Corneal Foreign Body","author":"AJ Camodeca","year":"2023","unstructured":"Camodeca AJ, Anderson EP (2023) Corneal Foreign Body. StatPearls Publishing, In StatPearls"},{"issue":"5","key":"6710_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ceo.14113","volume":"50","author":"M Cabrera-Aguas","year":"2022","unstructured":"Cabrera-Aguas M, Khoo P, Watson SL (2022) Infectious keratitis: A review. Clin Experiment Ophthalmol 50(5):543\u2013562. https:\/\/doi.org\/10.1111\/ceo.14113","journal-title":"Clin Experiment Ophthalmol"},{"key":"6710_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.07.005","author":"RB Singh","year":"2024","unstructured":"Singh RB, Dohlman TH, Ivanov A, Hall N, Ross C, Elze T, Miller JW, Lorch A, Yuksel E, Yin J, Dana R (2024) on behalf of the IRIS Registry Data Analytic Center Consortium, Corneal Opacity in the United States: An American Academy of Ophthalmology IRIS\u00ae Registry (Intelligent Research in Sight) Study. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2024.07.005","journal-title":"Ophthalmology"},{"issue":"7","key":"6710_CR9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/bjophthalmol-2019-314720","volume":"104","author":"R Mukhija","year":"2020","unstructured":"Mukhija R, Gupta N, Vashist P, Tandon R, Gupta SK (2020) Population-based assessment of visual impairment and pattern of corneal disease: results from the CORE (Corneal Opacity Rural Epidemiological) study. Br J Ophthalmol 104(7):994\u2013998. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314720","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"6710_CR10","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.ophtha.2007.01.014","volume":"114","author":"SR Durkin","year":"2007","unstructured":"Durkin SR, Casson RJ, Newland HS, Aung TH, Shein WK, Muecke JS, Selva D, Aung T (2007) Prevalence of trachoma-related trichiasis and corneal opacity in rural Myanmar: the Meiktila Eye Study. Ophthalmology 114(5):e7\u2013e11. https:\/\/doi.org\/10.1016\/j.ophtha.2007.01.014","journal-title":"Ophthalmology"},{"issue":"1","key":"6710_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/09286586.2017.1337912","volume":"25","author":"H Hashemi","year":"2018","unstructured":"Hashemi H, Pakzad R, Yekta A, Khabazkhoob M (2018) The Prevalence of Corneal Opacity in Rural Areas in Iran: A Population-based Study. Ophthalmic Epidemiol 25(1):21\u201326. https:\/\/doi.org\/10.1080\/09286586.2017.1337912","journal-title":"Ophthalmic Epidemiol"},{"issue":"6","key":"6710_CR12","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1007\/s40123-023-00782-1","volume":"12","author":"M Moshirfar","year":"2023","unstructured":"Moshirfar M, Wang Q, Theis J, Porter KC, Stoakes IM, Payne CJ, Hoopes PC (2023) Management of Corneal Haze After Photorefractive Keratectomy. Ophthalmol Therapy 12(6):2841\u20132862. https:\/\/doi.org\/10.1007\/s40123-023-00782-1","journal-title":"Ophthalmol Therapy"},{"issue":"3","key":"6710_CR13","first-page":"188","volume":"36","author":"AA Sarchahi","year":"2011","unstructured":"Sarchahi AA, Meimandi Parizi A, Eghtedari M, Keshavarz S (2011) Effect of different treatment regimen with dexamethasone and acetylcysteine on corneal wound healing in rabbits. Iran J Med Sci 36(3):188\u2013195","journal-title":"Iran J Med Sci"},{"issue":"1","key":"6710_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3928\/1081-597X-20030101-08","volume":"19","author":"Y Porges","year":"2003","unstructured":"Porges Y, Ben-Haim O, Hirsh A, Levinger S (2003) Phototherapeutic keratectomy with mitomycin C for corneal haze following photorefractive keratectomy for myopia. J Refract Surg 19(1):40\u201343. https:\/\/doi.org\/10.3928\/1081-597X-20030101-08","journal-title":"J Refract Surg"},{"issue":"1","key":"6710_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"CN McGhee","year":"2002","unstructured":"McGhee CN, Dean S, Danesh-Meyer H (2002) Locally administered ocular corticosteroids: benefits and risks. Drug Saf 25(1):33\u201355. https:\/\/doi.org\/10.2165\/00002018-200225010-00004","journal-title":"Drug Saf"},{"issue":"2","key":"6710_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00004397-199303320-00013","volume":"33","author":"RC Urban Jr","year":"1993","unstructured":"Urban RC Jr, Dreyer EB (1993) Corticosteroid-induced glaucoma. Int Ophthalmol Clin 33(2):135\u2013139. https:\/\/doi.org\/10.1097\/00004397-199303320-00013","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"6710_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/bjophthalmol-2021-320077","volume":"107","author":"N Raj","year":"2023","unstructured":"Raj N, Gupta N, Kumar D, Vashist P, Tandon R (2023) Population-based study on the prevalence, clinical characteristics and vision-related quality of life in patients with corneal opacity resulting from infectious keratitis: results from the Corneal Opacity Rural Epidemiological study. Br J Ophthalmol 107(4):476\u2013482. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-320077","journal-title":"Br J Ophthalmol"},{"issue":"3 Suppl","key":"6710_CR18","doi-asserted-by":"publisher","first-page":"S309","DOI":"10.3928\/1081-597X-19950502-25","volume":"11","author":"JD Carr","year":"1995","unstructured":"Carr JD, Patel R, Hersh PS (1995) Management of late corneal haze following photorefractive keratectomy. J Refract Surg 11(3 Suppl):S309\u2013S313. https:\/\/doi.org\/10.3928\/1081-597X-19950502-25","journal-title":"J Refract Surg"},{"issue":"2","key":"6710_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.exer.2007.10.014","volume":"86","author":"RR Mohan","year":"2008","unstructured":"Mohan RR, Stapleton WM, Sinha S, Netto MV, Wilson SE (2008) A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser. Exp Eye Res 86(2):235\u2013240. https:\/\/doi.org\/10.1016\/j.exer.2007.10.014","journal-title":"Exp Eye Res"},{"issue":"1","key":"6710_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0014-4835(02)00251-8","volume":"76","author":"RR Mohan","year":"2003","unstructured":"Mohan RR, Hutcheon AE, Choi R, Hong J, Lee J, Mohan RR, Ambr\u00f3sio R Jr, Zieske JD, Wilson SE (2003) Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res 76(1):71\u201387. https:\/\/doi.org\/10.1016\/s0014-4835(02)00251-8","journal-title":"Exp Eye Res"},{"issue":"9","key":"6710_CR21","first-page":"1959","volume":"40","author":"JV Jester","year":"1999","unstructured":"Jester JV, Huang J, Barry-Lane PA, Kao WW, Petroll WM, Cavanagh HD (1999) Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest Ophthalmol Vis Sci 40(9):1959\u20131967","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"6710_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00018-022-04184-7","volume":"79","author":"SE Wilson","year":"2022","unstructured":"Wilson SE (2022) Defective perlecan-associated basement membrane regeneration and altered modulation of transforming growth factor beta in corneal fibrosis. Cell Mol Life Sci 79(3):144. https:\/\/doi.org\/10.1007\/s00018-022-04184-7","journal-title":"Cell Mol Life Sci"},{"key":"6710_CR23","doi-asserted-by":"publisher","first-page":"109631","DOI":"10.1016\/j.exer.2023.109631","volume":"235","author":"TM Shiju","year":"2023","unstructured":"Shiju TM, Sampaio LP, Martinez VV, Hilgert GSL, Wilson SE (2023) Transforming growth factor beta-3 localization in the corneal response to epithelial-stromal injury and effects on corneal fibroblast transition to myofibroblasts. Exp Eye Res 235:109631. https:\/\/doi.org\/10.1016\/j.exer.2023.109631","journal-title":"Exp Eye Res"},{"key":"6710_CR24","doi-asserted-by":"publisher","first-page":"108594","DOI":"10.1016\/j.exer.2021.108594","volume":"207","author":"SE Wilson","year":"2021","unstructured":"Wilson SE (2021) TGF beta -1, -2 and -3 in the modulation of fibrosis in the cornea and other organs. Exp Eye Res 207:108594. https:\/\/doi.org\/10.1016\/j.exer.2021.108594","journal-title":"Exp Eye Res"},{"key":"6710_CR25","first-page":"161","volume":"16","author":"B Strzalka-Mrozik","year":"2010","unstructured":"Strzalka-Mrozik B, Stanik-Walentek A, Kapral M, Kowalczyk M, Adamska J, Gola J, Mazurek U (2010) Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas. Mol Vis 16:161\u2013166","journal-title":"Mol Vis"},{"issue":"6","key":"6710_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3109\/02713689609008901","volume":"15","author":"K Yoshino","year":"1996","unstructured":"Yoshino K, Garg R, Monroy D, Ji Z, Pflugfelder SC (1996) Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland. Curr Eye Res 15(6):615\u2013624. https:\/\/doi.org\/10.3109\/02713689609008901","journal-title":"Curr Eye Res"},{"issue":"9","key":"6710_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/ICO.0b013e3181cf98ff","volume":"29","author":"X Zheng","year":"2010","unstructured":"Zheng X, De Paiva CS, Rao K, Li DQ, Farley WJ, Stern M, Pflugfelder SC (2010) Evaluation of the transforming growth factor-beta activity in normal and dry eye human tears by CCL-185 cell bioassay. Cornea 29(9):1048\u20131054. https:\/\/doi.org\/10.1097\/ICO.0b013e3181cf98ff","journal-title":"Cornea"},{"issue":"23","key":"6710_CR28","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.3390\/ijms232314933","volume":"23","author":"N Fortingo","year":"2022","unstructured":"Fortingo N, Melnyk S, Sutton SH, Watsky MA, Bollag WB (2022) Innate Immune System Activation, Inflammation and Corneal Wound Healing. Int J Mol Sci 23(23):14933. https:\/\/doi.org\/10.3390\/ijms232314933","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6710_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/1566524011009060565","volume":"10","author":"A Tandon","year":"2010","unstructured":"Tandon A, Tovey JC, Sharma A, Gupta R, Mohan RR (2010) Role of transforming growth factor Beta in corneal function, biology and pathology. Curr Mol Med 10(6):565\u2013578. https:\/\/doi.org\/10.2174\/1566524011009060565","journal-title":"Curr Mol Med"},{"issue":"2","key":"6710_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.exer.2009.02.022","volume":"89","author":"SS Chaurasia","year":"2009","unstructured":"Chaurasia SS, Kaur H, de Medeiros FW, Smith SD, Wilson SE (2009) Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury. Exp Eye Res 89(2):133\u2013139. https:\/\/doi.org\/10.1016\/j.exer.2009.02.022","journal-title":"Exp Eye Res"},{"issue":"4","key":"6710_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00003226-199707000-00015","volume":"16","author":"J Weng","year":"1997","unstructured":"Weng J, Mohan RR, Li Q, Wilson SE (1997) IL-1 upregulates keratinocyte growth factor and hepatocyte growth factor mRNA and protein production by cultured stromal fibroblast cells: interleukin-1 beta expression in the cornea. Cornea 16(4):465\u2013471","journal-title":"Cornea"},{"issue":"2","key":"6710_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.exer.2009.03.001","volume":"89","author":"H Kaur","year":"2009","unstructured":"Kaur H, Chaurasia SS, Agrawal V, Suto C, Wilson SE (2009) Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1. Exp Eye Res 89(2):152\u2013158. https:\/\/doi.org\/10.1016\/j.exer.2009.03.001","journal-title":"Exp Eye Res"},{"key":"6710_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.exer.2014.09.012","volume":"142","author":"AA Torricelli","year":"2016","unstructured":"Torricelli AA, Santhanam A, Wu J, Singh V, Wilson SE (2016) The corneal fibrosis response to epithelial-stromal injury. Exp Eye Res 142:110\u2013118. https:\/\/doi.org\/10.1016\/j.exer.2014.09.012","journal-title":"Exp Eye Res"},{"issue":"8","key":"6710_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/sj.eye.6700574","volume":"17","author":"KM Meek","year":"2003","unstructured":"Meek KM, Leonard DW, Connon CJ, Dennis S, Khan S (2003) Transparency, swelling and scarring in the corneal stroma. Eye (Lond) 17(8):927\u2013936. https:\/\/doi.org\/10.1038\/sj.eye.6700574","journal-title":"Eye (Lond)"},{"issue":"5","key":"6710_CR35","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.exer.2005.09.021","volume":"82","author":"MV Netto","year":"2006","unstructured":"Netto MV, Mohan RR, Sinha S, Sharma A, Dupps W, Wilson SE (2006) Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res 82(5):788\u2013797. https:\/\/doi.org\/10.1016\/j.exer.2005.09.021","journal-title":"Exp Eye Res"},{"issue":"1","key":"6710_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.63.1.22","volume":"63","author":"SE Wilson","year":"2022","unstructured":"Wilson SE, Sampaio LP, Shiju TM, Hilgert GSL, de Oliveira RC (2022) Corneal Opacity: Cell Biological Determinants of the Transition From Transparency to Transient Haze to Scarring Fibrosis, and Resolution, After Injury. Invest Ophthalmol Vis Sci 63(1):22. https:\/\/doi.org\/10.1167\/iovs.63.1.22","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"6710_CR37","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1167\/iovs.13-13735","volume":"55","author":"HW Pan","year":"2014","unstructured":"Pan HW, Cui YH, Zeng JW (2014) NF-\u03baB mediates the survival of corneal myofibroblast induced by angiotensin II. Invest Ophthalmol Vis Sci 55(7):4220\u20134228. https:\/\/doi.org\/10.1167\/iovs.13-13735","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"6710_CR38","doi-asserted-by":"publisher","first-page":"10505","DOI":"10.1096\/fj.202001020R","volume":"34","author":"J Wang","year":"2020","unstructured":"Wang J, Kaplan N, Wysocki J, Yang W, Lu K, Peng H, Batlle D, Lavker RM (2020) The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation. FASEB J 34(8):10505\u201310515. https:\/\/doi.org\/10.1096\/fj.202001020R","journal-title":"FASEB J"},{"key":"6710_CR39","doi-asserted-by":"publisher","first-page":"108803","DOI":"10.1016\/j.exer.2021.108803","volume":"213","author":"LP Sampaio","year":"2021","unstructured":"Sampaio LP, Shiju TM, Hilgert GSL, de Oliveira RC, DeDreu J, Menko AS, Santhiago MR, Wilson SE (2021) Descemet\u2019s membrane injury and regeneration, and posterior corneal fibrosis, in rabbits. Exp Eye Res 213:108803. https:\/\/doi.org\/10.1016\/j.exer.2021.108803","journal-title":"Exp Eye Res"},{"issue":"2","key":"6710_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0012-1606(91)90081-d","volume":"143","author":"VM Paralkar","year":"1991","unstructured":"Paralkar VM, Vukicevic S, Reddi AH (1991) Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev Biol 143(2):303\u2013308. https:\/\/doi.org\/10.1016\/0012-1606(91)90081-d","journal-title":"Dev Biol"},{"key":"6710_CR41","doi-asserted-by":"publisher","first-page":"108940","DOI":"10.1016\/j.exer.2022.108940","volume":"216","author":"LP Sampaio","year":"2022","unstructured":"Sampaio LP, Hilgert GSL, Shiju TM, Murillo SE, Santhiago MR, Wilson SE (2022) Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet\u2019s membrane-endothelial excision in rabbits. Exp Eye Res 216:108940. https:\/\/doi.org\/10.1016\/j.exer.2022.108940","journal-title":"Exp Eye Res"},{"issue":"7","key":"6710_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.11.7.9","volume":"11","author":"LP Sampaio","year":"2022","unstructured":"Sampaio LP, Hilgert GSL, Shiju TM, Santhiago MR, Wilson SE (2022) Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury. Transl Vis Sci Technol 11(7):9. https:\/\/doi.org\/10.1167\/tvst.11.7.9","journal-title":"Transl Vis Sci Technol"},{"issue":"12","key":"6710_CR43","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3928\/1081597X-20221026-03","volume":"38","author":"LP Sampaio","year":"2022","unstructured":"Sampaio LP, Hilgert GSL, Shiju TM, Santhiago MR, Wilson SE (2022) Losartan Inhibition of Myofibroblast Generation and Late Haze (Scarring Fibrosis) After PRK in Rabbits. J Refract Surg 38(12):820\u2013829. https:\/\/doi.org\/10.3928\/1081597X-20221026-03","journal-title":"J Refract Surg"},{"key":"6710_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003527.Advanceonlinepublication.10.1097\/ICO.0000000000003527","author":"EG Rodgers","year":"2024","unstructured":"Rodgers EG, Al-Mohtaseb Z, Chen AJ (2024) Topical Losartan for Treating Corneal Haze After Ultraviolet-A\/Riboflavin Collagen Cross-Linking. Cornea. https:\/\/doi.org\/10.1097\/ICO.0000000000003527.Advanceonlinepublication.10.1097\/ICO.0000000000003527","journal-title":"Cornea"},{"issue":"11","key":"6710_CR45","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3928\/1081597X-20221018-02","volume":"38","author":"AL Pereira-Souza","year":"2022","unstructured":"Pereira-Souza AL, Ambr\u00f3sio R Jr, Bandeira F, Salom\u00e3o MQ, Souza Lima A, Wilson SE (2022) Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience. J Refract Surg 38(11):741\u2013746. https:\/\/doi.org\/10.3928\/1081597X-20221018-02","journal-title":"J Refract Surg"},{"issue":"3","key":"6710_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/jop.2022.0174","volume":"39","author":"SE Wilson","year":"2023","unstructured":"Wilson SE (2023) Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders. J Ocul Pharmacol Ther 39(3):191\u2013206. https:\/\/doi.org\/10.1089\/jop.2022.0174","journal-title":"J Ocul Pharmacol Ther"},{"key":"6710_CR47","unstructured":"Wilson SE. Topical Losartan for Corneal Scarring After Refractive Surgery. (CRSToday, Digital Platform, January 2024) https:\/\/crstoday.com\/articles\/jan-2024\/topical-losartan-for-corneal-scarring-after-refractive-surgery, Accessed: July 25th, 2024"},{"key":"6710_CR48","unstructured":"Mulla S, Patel P, Siddiqui WJ. Losartan (2024) In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526065\/. Accessed 26 Jul 2024"},{"key":"6710_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003476.Advanceonlinepublication.10.1097\/ICO.0000000000003476","author":"VV Martinez","year":"2024","unstructured":"Martinez VV, Dutra BAL, Sampaio LP, Shiju TM, Santhiago MR, Wilson SE (2024) Topical Losartan Inhibition of Myofibroblast Generation in Rabbit Corneas With Acute Incisions. Cornea. https:\/\/doi.org\/10.1097\/ICO.0000000000003476.Advanceonlinepublication.10.1097\/ICO.0000000000003476","journal-title":"Cornea"},{"issue":"9","key":"6710_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1167\/tvst.12.9.20","volume":"12","author":"LP Sampaio","year":"2023","unstructured":"Sampaio LP, Villabona-Martinez V, Shiju TM, Santhiago MR, Wilson SE (2023) Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits. Transl Vis Sci Technol 12(9):20. https:\/\/doi.org\/10.1167\/tvst.12.9.20","journal-title":"Transl Vis Sci Technol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06710-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06710-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T23:02:44Z","timestamp":1747782164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06710-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6710"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06710-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflicts of interest"}},{"value":"This review of the literature did not involve research with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The clinical photograph presented in this review was obtained from a patient who signed an institutional informed written consent allowing the use of clinical data, and patient\u2019s anonymity was ensured.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}